Inside Innovation featuring Dr. Catriona Jamieson. Roth Auditorium and Terrace, Sanford Consortium for Regenerative Medicine, 3rd Tuesdays from 4–6pm. 4:00 pm — Registration 4:15 pm — Welcome 4:20 pm — Presentation 4:40 pm — Q&A 5:00 pm — Refreshments/ Networking Catriona Jamieson, M.D., Ph.D., is Associate Professor of Medicine in the Division of Hematology-Oncology, Chief of the Division of Regenerative Medicine, Deputy Director of the Sanford Stem Cell Clinical Center, Co-Leader of the Hematologic Malignancies Program, and Director of Stem Cell Research at the Moores UCSD Cancer Center. Dr. Jamieson specializes in myeloproliferative disorders (MPDs) and leukemia. Myeloproliferative neoplasms are a family of uncommon but not rare degenerative disorders in which the body overproduces blood cells. Myeloproliferative neoplasms can cause many forms of blood clotting including heart attack, stroke, deep venous thrombosis, and pulmonary emboli and can develop into acute myelogenous leukemia. Although some effective treatments are available, they are laden with serious side effects. In addition, individuals can become resistant to the treatments. Dr. Jamieson studies the mutant stem cells and progenitor cells in myeloproliferative neoplasms. These cells can give rise to cancer stem cells. Cancer stem cells may lie low to evade chemotherapy and then activate again later, causing disease progression and resistance to treatment. Her goal is to find more selective, less toxic therapies. Inside Innovation is a presentation series featuring the latest innovative technologies developed by UC San Diego researchers. Get an inside look at what is happening in the labs, explore commercialization opportunities and inquire about licensing. UC San Diego Office of Innovation and Commercialization - providing campus-wide innovation and entrepreneurism support, building a dynamic entrepreneurial communit